CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model: SGP010
Published November 11, 2026 · Recall initiated: September 18, 2026
Summary
FDA records medical device Class II recall Z-0325-2027, published November 11, 2026 and initiated September 18, 2026. Recalling firm: Artivion, Inc; Status: Ongoing; Reported quantity: 1; Lot: Serial/Donor Number: 12617554/177871, UDI-DI: 00877234000478, Shipped: 22May2024, Implanted: 05June2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded.
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Artivion, Inc
- Distributor
- US Nationwide distribution in the state of IL.
- Lot
- Serial/Donor Number: 12617554/177871, UDI-DI: 00877234000478, Shipped: 22May2024, Implanted: 05June2024
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVeriSeq Onsite Server V2 REF: 20047000November 11, 2026
- FDASenographe PristinaNovember 11, 2026
- FDAIllumina DRAGEN Server for NextSeq 550Dx REF: 20086130,November 11, 2026
- FDA(1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved DecellularizedAugust 14, 2024
- FDACryoValve SG Pulmonary Human Heart Valve, SGPV00, Cryopreserved Decellularized Heart Valve Allograft PreparedAugust 14, 2024
- FDACryoValve SG Cryopreserved Pulmonary Human Heart ValveApril 24, 2024
Questions about this recall
Was CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model: SGP010 recalled?
Yes. FDA published recall Z-0325-2027 on November 11, 2026. Reported hazard: A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded.
What should I do if I have this product?
Voluntary: Firm initiated